NVDA+2.54%AAPL+1.32%GOOGL−1.62%MSFT+0.20%AMZN−0.10%TSM+1.60%SPCX+7.79%META+0.47%
StockVS

NASDAQ · Medical Devices · USD

Intelligent Bio Solutions Inc. (INBS) Stock Analysis

Intelligent Bio Solutions Inc. (INBS) is a Medical Devices stock listed on NASDAQ and quoted in US Dollar.

Last Updated: October 21, 2026

INBS

$1.73

+$0.06 (+3.59%)

Oct 21, 2026 · Market close

Compare

Price History

Hover for the daily close. The dotted line marks the period open.

Compare INBS with… →

INBS Key Statistics

As of Oct 21, 2026
Trading
Open
$1.76
Previous Close
$1.67
Day's Range
1.67–1.77
52-Week Range
1.35–24.90
Volume
39.70K
BetaHow much the share price moves relative to the wider market. 1.0 moves in line with it; above 1.0 swings more, below 1.0 less.
4.30
Valuation
Market Cap
$5.74M
P/E Ratio
unprofitable
Forward P/EShare price divided by forecast earnings for the year ahead, rather than the year just past.
4.94
P/S ratioMarket value divided by annual revenue. Useful for companies that are not yet profitable, where a P/E cannot be calculated.
1.36
EPS (ttm)Profit attributable to each share over the last twelve months.
−8.44
Financials (FY)
Revenue (FY)
$3.05M−1.90%
Net Income (FY)
−$10.57M
Profit marginThe share of revenue left as profit after all costs and taxes.
−294.91%
Shares OutstandingThe total number of shares held by all investors. Market value is this figure multiplied by the share price.
3.32M
1-Year Return
−83.68%
Dividend and dates
Avg Volume
148.52K

Only metrics the company reports are shown. Data provided by Yahoo Finance via yfinance. Updated daily.

Key facts

As of October 21, 2026, INBS closed at $1.73, −83.68% over 1 year.

Intelligent Bio Solutions Inc. (INBS) has a market capitalization of $5.74M.

In fiscal 2025, INBS reported revenue of $3.05M.

INBS Stock Return by Calendar Year

Intelligent Bio Solutions Inc. (INBS) return since Dec 2020: what $10,000 became

1 year
$10,000 $1,632
−83.68%
5 years
$10,000 $3
−99.97%
Since Dec 2020
$10,000 $0.65
−99.99%

If you had invested $10,000 in Intelligent Bio Solutions Inc. (INBS) at the close on December 23, 2020, the earliest close on record here, it would have been worth $0.65 at the close on October 21, 2026: −99.99% in total, −80.87% a year, over a partial period shorter than 10 years. A historical calculation from closing prices adjusted for splits and dividends, before fees and taxes.

Calendar-year returns computed from daily closing prices. Partial years are shown muted and marked with an asterisk.

YearReturn
2026 (partial year)−81.85%
2025−31.93%
2024−65.48%
2023−91.55%
2022−86.06%
2021−80.61%
2020 (partial year)−32.85%

As of October 21, 2026.

INBS Revenue and Earnings by Fiscal Year

FY ends June
Fiscal yearRevenueNet incomeNet margin
2025$3.05M−$10.57M−346.2%
2024$3.11M−$10.16M−326.4%
2023$1.26M−$10.63M−845.9%
2022$0.00−$8.31M—
Fiscal yearRevenueGross profitOperating incomeNet incomeNet margin
2025$3.05M$1.25M−$10.42M−$10.57M−346.2%
2024$3.11M$1.43M−$10.28M−$10.16M−326.4%
2023$1.26M$326.67K−$8.44M−$10.63M−845.9%
2022$0.00$0.00−$8.34M−$8.31M—

Annual figures as reported, in the company's reporting currency. As of June 30, 2025.

INBS Valuation vs Medical Devices Median

Median of 145 stocks
MetricINBSMedical Devices medianvs median
P/S ratio1.362.5346% below
Profit margin−294.91%−14.78%280.1 pts below

Medians across 145 Medical Devices stocks that report the metric. Medians, not averages, so one outlier cannot move them. As of October 21, 2026.

Recent News

All 14 articles ↓

News provided by third-party sources. Not financial advice.

Analysis

Data-derived

Company Overview

The market values Intelligent Bio Solutions Inc. (INBS) at $5.74M. It is classified in the Medical Devices industry, within the Healthcare sector. Headcount on file is 59.

INBS last closed at $1.73 on October 21, 2026. That is +$0.06 (+3.59%) against the previous close. Over the past 52 weeks the price has ranged from $1.35 to $24.90. The latest close sits 28.15% above that 52-week low.

Financial Health

Fiscal 2025 revenue came to $3.05M. Against the prior fiscal year total of $3.11M, that is a change of −1.90%. The same year closed with a net loss of $10.57M. Profit margin runs at −294.91%. That is 280.1 percentage points below the Medical Devices median of −14.78%. Earnings per share on a trailing basis come to −8.44.

Across the 4 fiscal years on file, revenue moves from $0.00 in 2022 to $3.05M in 2025. Of those 4 years, 0 report positive net income.

Valuation Assessment

The record shows negative trailing earnings, so no price-to-earnings ratio is published. The forward P/E on file is 4.94. Measured against sales, the shares trade at 1.36 times revenue. On price-to-sales that is 46.19% below the Medical Devices median of 2.53. The medians here are taken across 145 Medical Devices companies that report the metric.

The reported beta is 4.3. Daily returns over the trailing 5 years annualize to a volatility of 215.31%. The trailing one-year total return is −83.68%. Measured over 5 years, that is −79.81% a year compounded.

Growth & Income

The record shows no dividend for INBS.

Across the complete calendar years on file, 2025 returned −31.93% and 2023 returned −91.55%. Of the 5 complete calendar years on file, 0 finished higher. 2026 is still running; the total return is −81.85% year to date.

Peer Comparison

Intelligent Bio Solutions Inc. (INBS) operates in the Medical Devices industry. Here is how it compares to its closest peers by market capitalization:

Company Ticker Market Cap P/E Ratio
Intelligent Bio Solutions Inc. INBS $5.74M —
Abbott Laboratories ABT $173.92B 32.4
Medtronic plc. MDT $119.00B 22.9
Stryker Corporation SYK $114.15B 30.8

The Medical Devices industry average P/E ratio is 27.1x. Intelligent Bio Solutions Inc. has no P/E ratio because it is not currently profitable.

Every figure above is read from this page's own data on each daily rebuild. Informational only, not financial advice. As of October 21, 2026.

Related Medical Devices Stocks

ABT

Abbott Laboratories

$173.92B

 MDT

Medtronic plc.

$119.00B

 SYK

Stryker Corporation

$114.15B

 BSX

Boston Scientific Corporation

$64.33B

 EW

Edwards Lifesciences Corporation

$50.95B

 GEHC

GE HealthCare Technologies Inc.

$31.17B
View all Medical Devices stocks →

Popular Healthcare Stocks

LLY

Eli Lilly and Company

$1.13T

 JNJ

Johnson & Johnson

$621.22B

 ABBV

AbbVie Inc.

$503.27B

 UNH

UnitedHealth Group Incorporated

$374.30B

 MRK

Merck & Co., Inc.

$369.78B
View all Healthcare stocks →

About Intelligent Bio Solutions Inc.

Intelligent Bio Solutions Inc., a medical technology company, focused on developing and delivering non-invasive testing, and screening solutions in Asia Pacific, the United States, the United Kingdom, and internationally. The company operates intelligent fingerprinting drug screening system, a platform to analyze fingerprint sweat analysis to detect drugs abuse; and biosensor platform. The company was formerly known as GBS Inc. and changed its name to Intelligent Bio Solutions Inc. in October 2022. Intelligent Bio Solutions Inc. was incorporated in 2016 and is headquartered in New York, New York.

Visit website →